Request for Covid-19 Impact Assessment of this Report
Immunofluorescence assay (IFA) is a standard virologic procedure for detecting the presence of antibodies. The antibodies utilized in the assay are labeled with a fluorescence dye and enable them to tie up with its complementary antigen. The technique is used to analyze the presence of specific proteins in the culture, cell, patient’s body fluid sample, and others. The rising availability of government funding for life science research, growing awareness regarding the detection of diseases at the initial stage, coupled with the increasing prevalence of chronic diseases like cancer, cardiovascular, and other infectious diseases are the chief factors that may accelerate the market growth across the globe. For instance, as per the American Institute for Cancer Research, in 2018 there were around 18.1 million cancer cases were accounted around the world and it is anticipated to reach about 29.5 million by the end of 2040. Moreover, as per the World Health Organization (WHO), in 2020, chronic diseases are accounted for nearly 73% of all deaths and 60% of the global burden of diseases. Thereby, rising incidences of chronic diseases such as neurological disorders, cancer, autoimmune diseases, diabetes, lung disorders, and many others are propels the market demand around the world. However, high instrument costs and a dearth of skilled professionals impede the growth of the market over the forecast period of 2022-2028. Also, an increasing number of research activities is anticipated to act as a catalyzing factor for the market demand during the forecast period.
The key regions considered for the global Immunofluorescence Assay Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing research activities, availability of government funding, and presence of chief market players across the region. Whereas, Asia-Pacific is also anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as increasing spending on the R&D activities, as well as, the growing incidence of chronic & infectious diseases, would create lucrative growth prospects for the Immunofluorescence Assay Market across the Asia-Pacific region.
Major market players included in this report are:
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
PerkinElmer Inc.
Cell Signaling Technology, Inc.
Sino Biological, Inc.
Danaher Corporation
Enzo Biochem, Inc.
Becton, Dickinson and Company
Olympus Corporation
Nikon Corporation
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Products:
Antibodies
Reagents
Kits
Instruments
Consumables and Accessories
By Type:
Indirect Immunofluorescence
Direct Immunofluorescence
By Disease:
Cancer
Infectious Diseases
Cardiovascular Diseases
Autoimmune Diseases
Other Diseases
By End User:
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Hospitals & Diagnostic Centers
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Immunofluorescence Assay Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Immunofluorescence Assay Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Immunofluorescence Assay Market, by Products, 2020-2028 (USD Billion)
1.2.3. Global Immunofluorescence Assay Market, by Type, 2020-2028 (USD Billion)
1.2.4. Global Immunofluorescence Assay Market, by Disease, 2020-2028 (USD Billion)
1.2.5. Global Immunofluorescence Assay Market, by End User, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Immunofluorescence Assay Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Immunofluorescence Assay Market Dynamics
3.1. Immunofluorescence Assay Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Rising incidences of chronic diseases
3.1.1.2. Increasing government funding for life science research
3.1.2. Market Challenges
3.1.2.1. High instrument costs
3.1.2.2. Dearth of skilled professionals
3.1.3. Market Opportunities
3.1.3.1. Increasing number of research activities
Chapter 4. Global Immunofluorescence Assay Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Immunofluorescence Assay Market, by Products
6.1. Market Snapshot
6.2. Global Immunofluorescence Assay Market by Products, Performance - Potential Analysis
6.3. Global Immunofluorescence Assay Market Estimates & Forecasts by Products 2019-2028 (USD Billion)
6.4. Immunofluorescence Assay Market, Sub Segment Analysis
6.4.1. Antibodies
6.4.2. Reagents
6.4.3. Kits
6.4.4. Instruments
6.4.5. Consumables and Accessories
Chapter 7. Global Immunofluorescence Assay Market, by Type
7.1. Market Snapshot
7.2. Global Immunofluorescence Assay Market by Type, Performance - Potential Analysis
7.3. Global Immunofluorescence Assay Market Estimates & Forecasts by Type 2019-2028 (USD Billion)
7.4. Immunofluorescence Assay Market, Sub Segment Analysis
7.4.1. Indirect Immunofluorescence
7.4.2. Direct Immunofluorescence
Chapter 8. Global Immunofluorescence Assay Market, by Disease
8.1. Market Snapshot
8.2. Global Immunofluorescence Assay Market by Disease, Performance - Potential Analysis
8.3. Global Immunofluorescence Assay Market Estimates & Forecasts by Disease 2019-2028 (USD Billion)
8.4. Immunofluorescence Assay Market, Sub Segment Analysis
8.4.1. Cancer
8.4.2. Infectious Diseases
8.4.3. Cardiovascular Diseases
8.4.4. Autoimmune Diseases
8.4.5. Other Diseases
Chapter 9. Global Immunofluorescence Assay Market, by End User
9.1. Market Snapshot
9.2. Global Immunofluorescence Assay Market by End User, Performance - Potential Analysis
9.3. Global Immunofluorescence Assay Market Estimates & Forecasts by End User 2019-2028 (USD Billion)
9.4. Immunofluorescence Assay Market, Sub Segment Analysis
9.4.1. Academic & Research Institutes
9.4.2. Pharmaceutical & Biotechnology Companies
9.4.3. Contract Research Organizations
9.4.4. Hospitals & Diagnostic Centers
Chapter 10. Global Immunofluorescence Assay Market, Regional Analysis
10.1. Immunofluorescence Assay Market, Regional Market Snapshot
10.2. North America Immunofluorescence Assay Market
10.2.1. U.S. Immunofluorescence Assay Market
10.2.1.1. Products estimates & forecasts, 2019-2028
10.2.1.2. Type estimates & forecasts, 2019-2028
10.2.1.3. Disease estimates & forecasts, 2019-2028
10.2.1.4. End User estimates & forecasts, 2019-2028
10.2.2. Canada Immunofluorescence Assay Market
10.3. Europe Immunofluorescence Assay Market Snapshot
10.3.1. U.K. Immunofluorescence Assay Market
10.3.2. Germany Immunofluorescence Assay Market
10.3.3. France Immunofluorescence Assay Market
10.3.4. Spain Immunofluorescence Assay Market
10.3.5. Italy Immunofluorescence Assay Market
10.3.6. Rest of Europe Immunofluorescence Assay Market
10.4. Asia-Pacific Immunofluorescence Assay Market Snapshot
10.4.1. China Immunofluorescence Assay Market
10.4.2. India Immunofluorescence Assay Market
10.4.3. Japan Immunofluorescence Assay Market
10.4.4. Australia Immunofluorescence Assay Market
10.4.5. South Korea Immunofluorescence Assay Market
10.4.6. Rest of Asia Pacific Immunofluorescence Assay Market
10.5. Latin America Immunofluorescence Assay Market Snapshot
10.5.1. Brazil Immunofluorescence Assay Market
10.5.2. Mexico Immunofluorescence Assay Market
10.6. Rest of The World Immunofluorescence Assay Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Thermo Fisher Scientific, Inc.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Bio-Rad Laboratories, Inc.
11.2.3. PerkinElmer Inc.
11.2.4. Cell Signaling Technology, Inc.
11.2.5. Sino Biological, Inc.
11.2.6. Danaher Corporation
11.2.7. Enzo Biochem, Inc.
11.2.8. Becton, Dickinson and Company
11.2.9. Olympus Corporation
11.2.10. Nikon Corporation
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
TABLE 1. Global Immunofluorescence Assay Market, report scope
TABLE 2. Global Immunofluorescence Assay Market estimates & forecasts by Region 2019-2028 (USD Billion)
TABLE 3. Global Immunofluorescence Assay Market estimates & forecasts by Products 2019-2028 (USD Billion)
TABLE 4. Global Immunofluorescence Assay Market estimates & forecasts by Type 2019-2028 (USD Billion)
TABLE 5. Global Immunofluorescence Assay Market estimates & forecasts by Disease 2019-2028 (USD Billion)
TABLE 6. Global Immunofluorescence Assay Market estimates & forecasts by End User 2019-2028 (USD Billion)
TABLE 7. Global Immunofluorescence Assay Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 8. Global Immunofluorescence Assay Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 9. Global Immunofluorescence Assay Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 10. Global Immunofluorescence Assay Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 11. Global Immunofluorescence Assay Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 12. Global Immunofluorescence Assay Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 13. Global Immunofluorescence Assay Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 14. Global Immunofluorescence Assay Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 15. Global Immunofluorescence Assay Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 16. Global Immunofluorescence Assay Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 17. U.S. Immunofluorescence Assay Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 18. U.S. Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 19. U.S. Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 20. Canada Immunofluorescence Assay Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 21. Canada Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 22. Canada Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 23. UK Immunofluorescence Assay Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 24. UK Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 25. UK Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 26. Germany Immunofluorescence Assay Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 27. Germany Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 28. Germany Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 29. RoE Immunofluorescence Assay Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 30. RoE Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 31. RoE Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 32. China Immunofluorescence Assay Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 33. China Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 34. China Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 35. India Immunofluorescence Assay Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 36. India Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 37. India Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 38. Japan Immunofluorescence Assay Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 39. Japan Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 40. Japan Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 41. RoAPAC Immunofluorescence Assay Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 42. RoAPAC Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 43. RoAPAC Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 44. Brazil Immunofluorescence Assay Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 45. Brazil Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 46. Brazil Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 47. Mexico Immunofluorescence Assay Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 48. Mexico Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 49. Mexico Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 50. RoLA Immunofluorescence Assay Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 51. RoLA Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 52. RoLA Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 53. Row Immunofluorescence Assay Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 54. Row Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 55. Row Immunofluorescence Assay Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 56. List of secondary sources, used in the study of global Immunofluorescence Assay Market
TABLE 57. List of primary sources, used in the study of global Immunofluorescence Assay Market
TABLE 58. Years considered for the study
TABLE 59. Exchange rates considered
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
Summary
This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Con...